Dana-Farber Cancer Institute/Northeastern University Joint Program in Cancer Drug Development enables collaborative efforts to advance the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. The two institutions believe that projects that combine these approaches are likely to have rapid and high impact effects on cancer therapy.
More information can be found here.
Last Updated: September 9, 2019 by bencheriflab
Prof. Bencherif receives DFCI/NU joint program grant
Dana-Farber Cancer Institute/Northeastern University Joint Program in Cancer Drug Development enables collaborative efforts to advance the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. The two institutions believe that projects that combine these approaches are likely to have rapid and high impact effects on cancer therapy.
More information can be found here.
Category: Uncategorized
Latest News
Donations are welcome!
Make an impact in our research today!
Our laboratory accepts philanthropic donations. All financial contributions are tax-deductible.
Donate